Khurram Abbass, MD
Rheumatology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 33
- 10 carriers
- Offices
- 2
Offices
2 locations · Khurram Abbass MD Inc · 5 clinicians in this group
Plans that list them
33 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Abbass’s office at (408) 684-4104 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
33 of 33 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
| AARP Medicare Advantage from UHC CA-10 (HMO-POS) | UnitedHealthcare | Listed, may be out of date | Jun 10, 2026 |
California Medical Board record
Licence A129410 · Current
Licensed to practise in California · since 2014 · expires 2027-10-31 · University of the Punjab, Punjab Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$819,129
Medicare paid this office $819,129 for 339 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 20 | $182,524 | None |
| Injection, romosozumab-aqqg, 1 mg | 21 | $147,287 | None |
| Return visit (30+ min) | 258 | $90,502 | $117 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 69 | $40,645 | $75 |
| New patient visit (45+ min) | 149 | $22,762 | $153 |
See all 15 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 20 | $182,524 | None |
| Injection, romosozumab-aqqg, 1 mg | 21 | $147,287 | None |
| Return visit (30+ min) | 258 | $90,502 | $117 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 69 | $40,645 | $75 |
| New patient visit (45+ min) | 149 | $22,762 | $153 |
| Administration of chemotherapy into vein, 1 hour or less | 16 | $16,057 | $132 |
| Short return visit (20+ min) | 132 | $15,315 | $85 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 308 | $12,342 | $15 |
| Injection, denosumab, 1 mg | 21 | $10,114 | None |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 38 | $6,383 | $100 |
| Long return visit (40+ min) | 19 | $3,557 | $169 |
| New patient visit (60+ min) | 13 | $2,688 | $207 |
| Injection of drug or substance under skin or into muscle | 14 | $272 | $14 |
| Injection, methylprednisolone acetate, 1 mg | 37 | $254 | None |
| Injection, methylprednisolone acetate, 40 mg | 14 | $111 | None |
Who their Medicare patients are
339 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 12% · Women 74% · Also on Medicaid 57% · Health risk score 1.34. At or below the middle of the specialty; the typical rheumatology clinician is at 1.38.
Conditions among them: High blood pressure 75% · Diabetes 46% · Chronic kidney disease 27% · Coronary heart disease 24% · Heart failure 17% · Atrial fibrillation 16% · Depression 16% · COPD 9% · Dementia 9% · Cancer 8% · Stroke 6%.
The office billed $4,063,075, Medicare allowed $1,040,199 and paid $819,129; for 83,170 services of 40 kinds; $580,195 of it was for drugs given in the office and $238,933 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 339 | 83,170 | 75 | 1.34 | $4,063,075 | $819,129 |
| 2023 | 270 | 70,930 | 75 | 1.48 | $3,247,291 | $651,534 |
| 2022 | 228 | 40,082 | 74 | 1.49 | $1,936,115 | $405,861 |
| 2021 | 181 | 26,322 | 73 | 1.52 | $1,382,500 | $331,819 |
| 2020 | 155 | 13,632 | 73 | 1.82 | $980,585 | $241,119 |
| 2019 | 185 | 4,394 | 72 | 1.96 | $554,430 | $142,788 |
| 2018 | 227 | 948 | 74 | 1.82 | $208,947 | $74,046 |
| 2017 | 377 | 1,146 | 73 | 2.53 | $288,076 | $88,017 |
| 2016 | 232 | 491 | 73 | 2.94 | $135,273 | $42,351 |
| 2015 | 113 | 277 | 72 | 2.58 | $48,801 | $18,169 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 15 | $192,996 | None |
| Return visit (30+ min) | 210 | $68,749 | $114 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $32,643 | $75 |
| New patient visit (45+ min) | 118 | $17,434 | $148 |
| Administration of chemotherapy into vein, 1 hour or less | 13 | $13,118 | $135 |
| Short return visit (20+ min) | 97 | $9,619 | $81 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 38 | $6,486 | $94 |
| Injection, denosumab, 1 mg | 16 | $3,384 | None |
| Injection of drug or substance under skin or into muscle | 18 | $295 | $13 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 42 | $265 | None |
| Injection, methylprednisolone acetate, 40 mg | 18 | $140 | None |
2022: 10 services
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11 | $143,225 | None |
| Return visit (30+ min) | 157 | $43,445 | $114 |
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 20 | $34,121 | None |
| New patient visit (45+ min) | 94 | $13,771 | $146 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 40 | $13,086 | $112 |
| Short return visit (20+ min) | 82 | $9,328 | $78 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 18 | $9,216 | $82 |
| Injection, denosumab, 1 mg | 17 | $3,031 | None |
| Injection of drug or substance under skin or into muscle | 35 | $2,090 | $14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 43 | $328 | None |
2021: 7 services
| Return visit (30+ min) | 139 | $36,891 | $114 |
| Short return visit (20+ min) | 65 | $11,371 | $83 |
| New patient visit (45+ min) | 69 | $10,006 | $145 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 25 | $5,524 | $100 |
| Injection of drug or substance under skin or into muscle | 31 | $1,958 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $136 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $106 | None |
2020: 6 services
| Return visit (30+ min) | 123 | $29,721 | $96 |
| Short return visit (20+ min) | 74 | $9,790 | $67 |
| New patient visit (45+ min) | 34 | $4,951 | $146 |
| New patient visit (60+ min) | 15 | $2,725 | $182 |
| Injection of drug or substance under skin or into muscle | 25 | $1,167 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 11 | $87 | None |
2019: 10 services
| Return visit (30+ min) | 145 | $37,894 | $94 |
| Short return visit (20+ min) | 69 | $8,628 | $67 |
| New patient visit (60+ min) | 41 | $7,322 | $179 |
| New patient visit (45+ min) | 46 | $6,628 | $144 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 20 | $3,534 | $80 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $2,351 | $181 |
| Long return visit (40+ min) | 16 | $2,322 | $137 |
| Injection of drug or substance under skin or into muscle | 32 | $935 | $16 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $153 | None |
| Injection, methylprednisolone acetate, 40 mg | 11 | $86 | None |
2018: 11 services
| Return visit (30+ min) | 127 | $29,425 | $99 |
| New patient visit (60+ min) | 76 | $13,290 | $175 |
| New patient visit (45+ min) | 34 | $4,971 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,842 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $4,316 | $59 |
| Short return visit (20+ min) | 31 | $3,567 | $69 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 19 | $3,058 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,488 | $166 |
| Hospital discharge day management, more than 30 minutes | 19 | $1,680 | $88 |
| Injection of drug or substance under skin or into muscle | 19 | $474 | $19 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 17 | $185 | None |
2017: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 131 | $23,548 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $14,541 | $57 |
| Return visit (30+ min) | 48 | $11,703 | $99 |
| New patient visit (60+ min) | 51 | $8,935 | $175 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $8,895 | $159 |
| Hospital discharge day management, more than 30 minutes | 86 | $7,411 | $85 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 23 | $2,283 | $32 |
| Initial hospital observation care per day, typically 70 minutes | 13 | $1,818 | $140 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,451 | $104 |
| Aspiration and/or injection of fluid from large joint | 14 | $1,210 | $55 |
| Hospital observation care on day of discharge | 19 | $1,128 | $59 |
| Hospital discharge day management, 30 minutes or less | 16 | $927 | $58 |
| Injection of drug or substance under skin or into muscle | 14 | $439 | $26 |
2016: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $14,830 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,023 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $8,256 | $57 |
| Hospital discharge day management, more than 30 minutes | 62 | $5,419 | $87 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 90 | $11,844 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,325 | $111 |
| Hospital discharge day management, more than 30 minutes | 17 | $1,496 | $88 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,014 | $60 |
Medicaid work
$135,775 in 2024
Medicaid paid $135,775 for 1,399 billed services this clinician did in 2024, up to 69 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 80 | $133,106 |
| Return visit (30+ min) | 618 | $1,920 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 239 | $593 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 397 | $157 |
| New patient visit (45+ min) | 51 | $0 |
| Short return visit (20+ min) | 14 | $0 |
| 2024 | 1,399 | 6 | 69 | $135,775 |
| 2023 | 2,349 | 8 | 117 | $259,896 |
| 2022 | 1,245 | 7 | 81 | $128,788 |
| 2021 | 1,071 | 4 | 68 | $978 |
| 2020 | 873 | 4 | 63 | $299 |
| 2019 | 778 | 3 | 56 | $88 |
| 2018 | 381 | 2 | 51 | $39 |
See the largest Medicaid services in earlier years
2023
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 174 | $254,258 |
| Return visit (30+ min) | 1,195 | $2,937 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 377 | $948 |
| New patient visit (45+ min) | 228 | $853 |
| Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug | 102 | $442 |
| Short return visit (20+ min) | 179 | $331 |
| DRAIN/INJ JOINT/BURSA W/US | 32 | $100 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 62 | $27 |
2022
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 69 | $127,985 |
| Return visit (30+ min) | 794 | $478 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 122 | $227 |
| Short return visit (20+ min) | 110 | $69 |
| DRAIN/INJ JOINT/BURSA W/US | 16 | $17 |
| Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | 19 | $12 |
| New patient visit (45+ min) | 115 | $0 |
2021
| Return visit (30+ min) | 694 | $440 |
| New patient visit (45+ min) | 95 | $287 |
| Short return visit (20+ min) | 197 | $135 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 85 | $117 |
2020
| Return visit (30+ min) | 605 | $197 |
| Short return visit (20+ min) | 239 | $90 |
| Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | 13 | $12 |
| New patient visit (45+ min) | 16 | $0 |
2019
| Return visit (30+ min) | 614 | $73 |
| Short return visit (20+ min) | 119 | $15 |
| New patient visit (45+ min) | 45 | $0 |
2018
| Return visit (30+ min) | 365 | $39 |
| New patient visit (45+ min) | 16 | $0 |
Drugs they prescribed that Part D paid
$1,631,555
Pharmacies billed $1,631,555 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,348 generic and 365 brand-name prescriptions · $1,631,555 in drug cost · 16 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Enbrel Sureclick | 57 | $415,913 | $7,297 |
| Tymlos | 51 | $132,817 | $2,604 |
| Evenity (2 Syringes) | 50 | $120,093 | $2,402 |
| Humira(Cf) | 16 | $115,760 | $7,235 |
| Prolia | 42 | $71,770 | $1,709 |
See all 23 drugs
| Enbrel Sureclick | 57 | $415,913 | $7,297 |
| Tymlos | 51 | $132,817 | $2,604 |
| Evenity (2 Syringes) | 50 | $120,093 | $2,402 |
| Humira(Cf) | 16 | $115,760 | $7,235 |
| Prolia | 42 | $71,770 | $1,709 |
| Xeljanz Xr | 11 | $62,067 | $5,642 |
| Orencia Clickject | 11 | $60,496 | $5,500 |
| Leflunomide | 86 | $5,255 | $61 |
| Hydroxychloroquine Sulfate | 124 | $4,374 | $35 |
| Methotrexate | 175 | $3,191 | $18 |
| Diclofenac | 124 | $2,844 | $23 |
| Alendronate | 176 | $1,817 | $10 |
| Mycophenolate Mofetil | 16 | $1,428 | $89 |
| Colchicine | 31 | $1,066 | $34 |
| Gabapentin | 56 | $886 | $16 |
| Prednisone | 237 | $750 | $3 |
| Azathioprine | 25 | $700 | $28 |
| Allopurinol | 58 | $476 | $8 |
| Omeprazole | 28 | $442 | $16 |
| Betamethasone Dipropionate | 18 | $366 | $20 |
| Folic Acid | 42 | $351 | $8 |
| Sulfasalazine | 16 | $200 | $13 |
| Triamcinolone Acetonide | 28 | $144 | $5 |
Year by year
| 2024 | 1,734 | 465 | None | 21% | $1,631,555 |
| 2023 | 1,659 | 429 | None | 14% | $1,200,840 |
| 2022 | 2,415 | 403 | None | 16% | $2,107,488 |
| 2021 | 2,353 | 359 | None | 18% | $1,765,629 |
| 2020 | 2,297 | 272 | None | 22% | $1,511,482 |
| 2019 | 2,161 | 284 | None | 16% | $1,130,385 |
| 2018 | 1,547 | 242 | None | 15% | $694,571 |
| 2017 | 834 | 226 | 2% (18) | None | $244,280 |
| 2016 | 1,009 | 184 | None | None | $339,260 |
| 2015 | 602 | 128 | None | None | $409,880 |
| 2014 | 33 | 12 | 0% (0) | None | $554 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Humira(Cf) | 30 | $236,254 | $7,875 |
| Enbrel Sureclick | 30 | $215,679 | $7,189 |
| Benlysta | 21 | $104,220 | $4,963 |
| Orencia Clickject | 15 | $85,287 | $5,686 |
| Prolia | 48 | $79,431 | $1,655 |
| Kineret | 11 | $56,642 | $5,149 |
| Leflunomide | 165 | $17,919 | $109 |
| Hydroxychloroquine Sulfate | 174 | $14,737 | $85 |
| Methotrexate | 167 | $6,109 | $37 |
| Alendronate | 212 | $4,203 | $20 |
| Diclofenac | 51 | $1,624 | $32 |
| Colchicine | 30 | $1,516 | $51 |
| Prednisone | 245 | $1,379 | $6 |
| Azathioprine | 26 | $1,086 | $42 |
| Allopurinol | 77 | $1,078 | $14 |
| Sulfasalazine | 18 | $820 | $46 |
| Gabapentin | 58 | $770 | $13 |
| Omeprazole | 27 | $525 | $19 |
| Folic Acid | 51 | $283 | $6 |
| Triamcinolone Acetonide | 14 | $71 | $5 |
2022: 26 drugs
| Ilaris | 12 | $437,197 | $36,433 |
| Enbrel Sureclick | 65 | $420,381 | $6,467 |
| Humira(Cf) | 48 | $307,474 | $6,406 |
| Cosentyx Pen (2 Pens) | 26 | $160,702 | $6,181 |
| Benlysta | 26 | $118,528 | $4,559 |
| Prolia | 70 | $102,904 | $1,470 |
| Orencia Clickject | 15 | $78,033 | $5,202 |
| Enbrel | 11 | $76,339 | $6,940 |
| Forteo | 11 | $46,242 | $4,204 |
| Tymlos | 12 | $28,474 | $2,373 |
| Leflunomide | 223 | $24,128 | $108 |
| Hydroxychloroquine Sulfate | 290 | $20,078 | $69 |
| Methotrexate | 259 | $11,813 | $46 |
| Mycophenolate Mofetil | 39 | $5,470 | $140 |
| Alendronate | 287 | $4,156 | $14 |
| Colchicine | 29 | $3,331 | $115 |
| Prednisone | 336 | $2,149 | $6 |
| Allopurinol | 102 | $1,613 | $16 |
| Azathioprine | 24 | $1,526 | $64 |
| Gabapentin | 129 | $1,399 | $11 |
| Diclofenac | 44 | $930 | $21 |
| Sulfasalazine | 23 | $782 | $34 |
| Omeprazole | 40 | $599 | $15 |
| Folic Acid | 85 | $537 | $6 |
| Betamethasone Dipropionate | 16 | $434 | $27 |
| Triamcinolone Acetonide | 41 | $353 | $9 |
2021: 30 drugs
| Enbrel Sureclick | 48 | $288,501 | $6,010 |
| Humira(Cf) | 38 | $227,854 | $5,996 |
| Forteo | 44 | $177,187 | $4,027 |
| Orencia Clickject | 31 | $150,265 | $4,847 |
| Tymlos | 49 | $105,858 | $2,160 |
| Prolia | 61 | $82,802 | $1,357 |
| Kineret | 17 | $76,996 | $4,529 |
| Benlysta | 16 | $68,426 | $4,277 |
| Humira | 11 | $63,997 | $5,818 |
| Rinvoq | 12 | $61,651 | $5,138 |
| Hydroxychloroquine Sulfate | 276 | $19,137 | $69 |
| Leflunomide | 117 | $13,039 | $111 |
| Methotrexate | 253 | $10,183 | $40 |
| Mycophenolate Mofetil | 40 | $4,209 | $105 |
| Alendronate | 234 | $2,889 | $12 |
| Colchicine | 18 | $2,853 | $158 |
| Prednisone | 353 | $2,573 | $7 |
| Azathioprine | 35 | $2,160 | $62 |
| Gabapentin | 143 | $1,586 | $11 |
| Allopurinol | 80 | $1,411 | $18 |
| Diclofenac | 36 | $994 | $28 |
| Betamethasone Dipropionate | 17 | $974 | $57 |
| Sulfasalazine | 27 | $883 | $33 |
| Ultra-Fine Mini Pen Needle | 34 | $511 | $15 |
| Omeprazole | 30 | $500 | $17 |
| Folic Acid | 63 | $390 | $6 |
| Triamcinolone Acetonide | 22 | $291 | $13 |
| Meloxicam | 26 | $108 | $4 |
| Vitamin D2 | 11 | $106 | $10 |
| Naproxen | 14 | $77 | $6 |
2020: 31 drugs
| Forteo | 101 | $370,512 | $3,668 |
| Humira(Cf) | 39 | $221,763 | $5,686 |
| Orencia Clickject | 41 | $191,699 | $4,676 |
| Enbrel Sureclick | 27 | $148,537 | $5,501 |
| Tymlos | 43 | $84,940 | $1,975 |
| Humira | 12 | $64,444 | $5,370 |
| Prolia | 50 | $63,699 | $1,274 |
| Xeljanz Xr | 12 | $55,404 | $4,617 |
| Kineret | 12 | $51,326 | $4,277 |
| Benlysta | 13 | $49,581 | $3,814 |
| Hydroxychloroquine Sulfate | 311 | $22,430 | $72 |
| Methotrexate | 265 | $9,934 | $37 |
| Leflunomide | 73 | $7,993 | $109 |
| Mycophenolate Mofetil | 40 | $4,279 | $107 |
| Mitigare | 20 | $4,053 | $203 |
| Colchicine | 18 | $3,075 | $171 |
| Azathioprine | 62 | $2,726 | $44 |
| Prednisone | 394 | $2,629 | $7 |
| Alendronate | 142 | $1,465 | $10 |
| Gabapentin | 119 | $1,459 | $12 |
| Ultra-Fine Mini Pen Needle | 74 | $1,011 | $14 |
| Allopurinol | 62 | $964 | $16 |
| Omeprazole | 50 | $661 | $13 |
| Sulfasalazine | 11 | $415 | $38 |
| Methotrexate | 28 | $396 | $14 |
| Folic Acid | 42 | $293 | $7 |
| Triamcinolone Acetonide | 22 | $230 | $10 |
| Ultra-Fine Short Pen Needle | 12 | $161 | $13 |
| Nabumetone | 12 | $148 | $12 |
| Meloxicam | 13 | $65 | $5 |
| Insulin | 11 | $26 | $2 |
2019: 29 drugs
| Forteo | 77 | $268,010 | $3,481 |
| Humira(Cf) | 35 | $179,684 | $5,134 |
| Enbrel Sureclick | 25 | $128,504 | $5,140 |
| Enbrel Mini | 20 | $108,816 | $5,441 |
| Orencia Clickject | 20 | $87,600 | $4,380 |
| Prolia | 45 | $54,384 | $1,209 |
| Xeljanz Xr | 11 | $47,481 | $4,316 |
| Benlysta | 12 | $42,500 | $3,542 |
| Hydroxychloroquine Sulfate | 323 | $22,037 | $68 |
| Tymlos | 12 | $21,974 | $1,831 |
| Leflunomide | 131 | $11,695 | $89 |
| Methotrexate | 259 | $8,183 | $32 |
| Mycophenolate Mofetil | 46 | $4,782 | $104 |
| Azathioprine | 70 | $2,400 | $34 |
| Prednisone | 321 | $2,274 | $7 |
| Gabapentin | 133 | $1,806 | $14 |
| Alendronate | 146 | $1,142 | $8 |
| Allopurinol | 53 | $932 | $18 |
| Voltaren | 12 | $874 | $73 |
| Ultra-Fine Mini Pen Needle | 36 | $581 | $16 |
| Omeprazole | 50 | $569 | $11 |
| Diclofenac | 18 | $481 | $27 |
| Ultra-Fine Short Pen Needle | 16 | $358 | $22 |
| Methotrexate | 36 | $352 | $10 |
| Triamcinolone Acetonide | 47 | $320 | $7 |
| Nabumetone | 11 | $183 | $17 |
| Naproxen | 19 | $115 | $6 |
| Meloxicam | 15 | $86 | $6 |
| Insulin | 14 | $42 | $3 |
2018: 21 drugs
| Forteo | 54 | $182,578 | $3,381 |
| Humira | 24 | $117,605 | $4,900 |
| Enbrel Sureclick | 24 | $115,694 | $4,821 |
| Orencia Clickject | 18 | $76,032 | $4,224 |
| Xeljanz Xr | 13 | $54,244 | $4,173 |
| Prolia | 18 | $21,229 | $1,179 |
| Hydroxychloroquine Sulfate | 274 | $19,053 | $70 |
| Leflunomide | 82 | $9,632 | $117 |
| Methotrexate | 169 | $5,807 | $34 |
| Mycophenolate Mofetil | 30 | $2,637 | $88 |
| Prednisone | 241 | $1,804 | $7 |
| Gabapentin | 116 | $1,341 | $12 |
| Azathioprine | 34 | $1,106 | $33 |
| Alendronate | 95 | $757 | $8 |
| Celecoxib | 11 | $588 | $53 |
| Omeprazole | 46 | $462 | $10 |
| Allopurinol | 17 | $290 | $17 |
| Methotrexate | 16 | $198 | $12 |
| Naproxen | 15 | $111 | $7 |
| Meloxicam | 14 | $75 | $5 |
| Triamcinolone Acetonide | 12 | $61 | $5 |
2017: 13 drugs
| Humira | 17 | $76,256 | $4,486 |
| Humira | 13 | $57,989 | $4,461 |
| Hydroxychloroquine Sulfate | 79 | $9,934 | $126 |
| Methotrexate | 104 | $4,000 | $38 |
| Prednisone | 172 | $1,385 | $8 |
| Azathioprine | 37 | $1,378 | $37 |
| Gabapentin | 50 | $846 | $17 |
| Allopurinol | 30 | $326 | $11 |
| Amoxicillin-Clavulanate Potass | 14 | $160 | $11 |
| Levofloxacin | 23 | $148 | $6 |
| Omeprazole | 12 | $71 | $6 |
| Hydrocodone-Acetaminophen | 11 | $54 | $5 |
| Furosemide | 13 | $42 | $3 |
2016: 15 drugs
| Hydroxychloroquine Sulfate | 168 | $28,682 | $171 |
| Methotrexate | 80 | $2,870 | $36 |
| Prednisone | 236 | $2,642 | $11 |
| Colchicine | 12 | $2,369 | $197 |
| Azathioprine | 61 | $1,769 | $29 |
| Leflunomide | 12 | $1,531 | $128 |
| Pilocarpine | 11 | $1,124 | $102 |
| Gabapentin | 37 | $522 | $14 |
| Allopurinol | 43 | $426 | $10 |
| Sulfasalazine | 11 | $345 | $31 |
| Omeprazole | 27 | $229 | $8 |
| Methotrexate | 19 | $216 | $11 |
| Citalopram Hbr | 22 | $148 | $7 |
| Alendronate | 12 | $73 | $6 |
| Amlodipine Besylate | 12 | $20 | $2 |
2015: 9 drugs
| Enbrel | 11 | $38,173 | $3,470 |
| Actemra | 11 | $31,751 | $2,886 |
| Hydroxychloroquine Sulfate | 93 | $14,445 | $155 |
| Leflunomide | 18 | $2,465 | $137 |
| Methotrexate | 56 | $2,110 | $38 |
| Prednisone | 174 | $2,034 | $12 |
| Azathioprine | 31 | $682 | $22 |
| Sulfasalazine | 14 | $507 | $36 |
| Gabapentin | 18 | $160 | $9 |
2014: 1 drug
| Prednisone | 13 | $94 | $7 |
Money from drug and device companies
$3,267 in 2025
| 2025 | 16 | 123 | None | $3,267 |
| 2024 | 21 | 154 | $2,160 | $5,596 |
| 2023 | 16 | 128 | None | $2,254 |
| 2022 | 8 | 55 | None | $892 |
| 2021 | 9 | 38 | None | $498 |
| 2020 | 3 | 7 | None | $110 |
| 2019 | 14 | 23 | None | $660 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $1,110 | 30 payments
|
| Amgen | Evenity | $605 | 25 payments
|
| Ucb | Bimzelx | $305 | 8 payments
|
| GlaxoSmithKline | Benlysta | $239 | 9 payments
|
| Aurinia Pharma U.S. | Lupkynis | $210 | 10 payments
|
| Radius Health | Tymlos | $189 | 10 payments
|
See all 115 published payments
| Abbvie | Meals · 2025-12-30 | Rinvoq | $29 |
| ANI Pharmaceuticals | Meals · 2025-12-30 | Purified Cortrophin Gel | $14 |
| Abbvie | Meals · 2025-12-21 | Rinvoq | $2 |
| Radius Health | Meals · 2025-12-15 | Tymlos | $32 |
| Abbvie | Meals · 2025-12-11 | Skyrizi | $125 |
| Amgen | Meals · 2025-12-09 | Otezla | $25 |
| Abbvie | Meals · 2025-11-25 | Rinvoq | $7 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-25 | Saphnelo | $18 |
| Aurinia Pharma U.S. | Meals · 2025-11-25 | Lupkynis | $27 |
| Abbvie | Meals · 2025-11-20 | Skyrizi | $122 |
| Amgen | Meals · 2025-11-18 | Evenity | $29 |
| GlaxoSmithKline | Meals · 2025-11-17 | Benlysta | $19 |
| Amgen | Meals · 2025-11-11 | Evenity | $124 |
| Genentech USA | Meals · 2025-11-04 | Gazyva | $28 |
| Abbvie | Meals · 2025-10-31 | Rinvoq | $14 |
| GlaxoSmithKline | Meals · 2025-10-30 | Benlysta | $26 |
| Abbvie | Meals · 2025-10-30 | Rinvoq | $1 |
| Abbvie | Meals · 2025-10-29 | Rinvoq | $8 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-28 | Saphnelo | $22 |
| Radius Health | Meals · 2025-10-22 | Tymlos | $24 |
| Ucb | Meals · 2025-10-21 | Bimzelx | $22 |
| Mallinckrodt Hospital Products | Meals · 2025-10-20 | Acthar | $25 |
| Aurinia Pharma U.S. | Meals · 2025-10-17 | Lupkynis | $25 |
| Amgen | Meals · 2025-10-14 | Otezla | $29 |
| Abbvie | Meals · 2025-09-24 | Rinvoq | $27 |
| Amgen | Meals · 2025-09-22 | Evenity | $31 |
| ANI Pharmaceuticals | Meals · 2025-09-15 | Purified Cortrophin Gel | $15 |
| Amgen | Meals · 2025-09-11 | Tavneos | $19 |
| Aurinia Pharma U.S. | Meals · 2025-09-10 | Lupkynis | $25 |
| Sobi | Meals · 2025-09-04 | Kineret | $28 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-02 | Saphnelo | $20 |
| GlaxoSmithKline | Meals · 2025-08-28 | Benlysta | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-08-26 | Orencia | $23 |
| Radius Health | Meals · 2025-08-21 | Tymlos | $22 |
| Radius Health | Meals · 2025-08-21 | Tymlos | $3 |
| Amgen | Meals · 2025-08-20 | Evenity | $17 |
| Pfizer | Meals · 2025-08-19 | Xeljanz | $29 |
| Mallinckrodt Hospital Products | Meals · 2025-08-18 | Acthar | $27 |
| Alexion Pharmaceuticals | Meals · 2025-08-12 | Strensiq | $30 |
| Amgen | Meals · 2025-08-11 | Otezla | $7 |
| Amgen | Meals · 2025-08-05 | Evenity | $29 |
| Abbvie | Meals · 2025-08-01 | Rinvoq | $19 |
| Ucb | Meals · 2025-07-24 | Bimzelx | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-21 | Saphnelo | $19 |
| Aurinia Pharma U.S. | Meals · 2025-07-18 | Lupkynis | $27 |
| Amgen | Meals · 2025-07-15 | Otezla | $21 |
| Abbvie | Meals · 2025-07-14 | Rinvoq | $6 |
| Abbvie | Meals · 2025-07-10 | Rinvoq | $24 |
| Radius Health | Meals · 2025-07-09 | Tymlos | $23 |
| GlaxoSmithKline | Meals · 2025-07-08 | Benlysta | $31 |
| Amgen | Meals · 2025-06-24 | Krystexxa | $28 |
| Mallinckrodt Hospital Products | Meals · 2025-06-23 | Acthar | $18 |
| Abbvie | Meals · 2025-06-19 | Rinvoq | $122 |
| Amgen | Meals · 2025-06-17 | Tavneos | $13 |
| Abbvie | Meals · 2025-06-15 | Rinvoq | $12 |
| GlaxoSmithKline | Meals · 2025-06-12 | Benlysta | $30 |
| Ucb | Meals · 2025-06-11 | Bimzelx | $35 |
| Radius Health | Meals · 2025-06-09 | Tymlos | $24 |
| Aurinia Pharma U.S. | Meals · 2025-06-06 | Lupkynis | $20 |
| Abbvie | Meals · 2025-05-29 | Skyrizi | $20 |
| Abbvie | Meals · 2025-05-29 | Skyrizi | $2 |
| GlaxoSmithKline | Meals · 2025-05-20 | Benlysta | $28 |
| Lilly USA | Meals · 2025-05-19 | Taltz | $23 |
| Celltrion USA | Meals · 2025-05-16 | Vegzelma | $22 |
| Abbvie | Meals · 2025-05-15 | Skyrizi | $24 |
| Ucb | Meals · 2025-05-14 | Bimzelx | $6 |
| Ucb | Meals · 2025-05-13 | Bimzelx | $37 |
| Amgen | Meals · 2025-05-13 | Evenity | $17 |
| Aurinia Pharma U.S. | Meals · 2025-05-06 | Lupkynis | $26 |
| Abbvie | Meals · 2025-05-02 | Rinvoq | $4 |
| Abbvie | Meals · 2025-05-02 | Rinvoq | $29 |
| Abbvie | Meals · 2025-05-01 | Rinvoq | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-29 | Orencia | $22 |
| Abbvie | Meals · 2025-04-28 | Rinvoq | $14 |
| Amgen | Meals · 2025-04-28 | Otezla | $6 |
| Radius Health | Meals · 2025-04-28 | Tymlos | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-24 | Saphnelo | $68 |
| Pfizer | Meals · 2025-04-24 | Xeljanz | $34 |
| GlaxoSmithKline | Meals · 2025-04-22 | Benlysta | $23 |
| Amgen | Meals · 2025-04-21 | Krystexxa | $25 |
| Abbvie | Meals · 2025-04-17 | Rinvoq | $27 |
| Ucb | Meals · 2025-04-17 | Bimzelx | $125 |
| Amgen | Meals · 2025-04-17 | Krystexxa | $10 |
| Amgen | Meals · 2025-04-16 | Krystexxa | $3 |
| Abbvie | Meals · 2025-04-10 | None | $124 |
| Amgen | Meals · 2025-04-10 | Otezla | $23 |
| Abbvie | Meals · 2025-04-09 | Rinvoq | $28 |
| Amgen | Meals · 2025-04-03 | Tavneos | $19 |
| Abbvie | Meals · 2025-04-01 | Rinvoq | $13 |
| Aurinia Pharma U.S. | Meals · 2025-03-25 | Lupkynis | $26 |
| Radius Health | Meals · 2025-03-17 | Tymlos | $2 |
| Radius Health | Meals · 2025-03-17 | Tymlos | $14 |
| Abbvie | Meals · 2025-03-11 | Rinvoq | $12 |
| Amgen | Meals · 2025-03-06 | Evenity | $34 |
| Genentech USA | Meals · 2025-03-04 | Actemra | $34 |
| GlaxoSmithKline | Meals · 2025-03-03 | Benlysta | $30 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $119 |
| Aurinia Pharma U.S. | Meals · 2025-02-25 | Lupkynis | $23 |
| Pfizer | Meals · 2025-02-18 | Xeljanz | $32 |
| Abbvie | Meals · 2025-02-17 | Rinvoq | $12 |
| Ucb | Meals · 2025-02-11 | Cimzia | $30 |
| Amgen | Meals · 2025-02-10 | Otezla | $10 |
| Abbvie | Meals · 2025-02-06 | None | $116 |
| GlaxoSmithKline | Meals · 2025-02-04 | Benlysta | $29 |
| Amgen | Meals · 2025-01-30 | Tavneos | $10 |
| Amgen | Meals · 2025-01-30 | Evenity | $28 |
| Amgen | Meals · 2025-01-23 | Otezla | $24 |
| Amgen | Meals · 2025-01-21 | Krystexxa | $25 |
| Abbvie | Meals · 2025-01-17 | Rinvoq | $29 |
| Radius Health | Meals · 2025-01-15 | Tymlos | $23 |
| Genentech USA | Meals · 2025-01-13 | Actemra | $29 |
| Sobi | Meals · 2025-01-09 | Kineret | $26 |
| Ucb | Meals · 2025-01-08 | Bimzelx | $27 |
| Aurinia Pharma U.S. | Meals · 2025-01-07 | Lupkynis | $7 |
| Aurinia Pharma U.S. | Meals · 2025-01-07 | Lupkynis | $4 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,596
| Janssen Biotech | Tremfya | $2,430 | 12 payments
|
| Abbvie | Rinvoq | $861 | 34 payments
|
| Amgen | Enbrel | $513 | 26 payments
|
| Ucb | Cimzia | $308 | 12 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $217 | 10 payments
|
| Genentech USA | Actemra | $169 | 7 payments
|
| GlaxoSmithKline | Benlysta | $161 | 9 payments
|
| Radius Health | Tymlos | $153 | 7 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $122 | 6 payments
|
| Aurinia Pharma U.S. | Lupkynis | $107 | 4 payments
|
| Fresenius Kabi USA | Idacio | $93 | 3 payments
|
| Pfizer | Xeljanz | $73 | 3 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $71 | 3 payments
|
| Sobi | Kineret | $65 | 3 payments
|
| Alexion Pharmaceuticals | Strensiq | $60 | 2 payments
|
| Lilly USA | Taltz | $50 | 2 payments
|
| Ultragenyx Pharmaceutical | Crysvita | $48 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $29 | 1 payment
|
| ANI Pharmaceuticals | Purified Cortrophin Gel | $23 | 1 payment
|
| Myriad Genetic Laboratories | Myrisk | $23 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $20 | 1 payment
|
2023: $2,254
| Ucb | Cimzia | $432 | 18 payments
|
| AbbVie | Rinvoq | $308 | 24 payments
|
| Amgen | Enbrel | $259 | 16 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $254 | 11 payments
|
| Janssen Biotech | Tremfya | $233 | 11 payments
|
| Radius Health | Tymlos | $143 | 7 payments
|
| Pfizer | Xeljanz | $130 | 15 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $117 | 4 payments
|
| Fresenius Kabi USA | Idacio | $111 | 3 payments
|
| GlaxoSmithKline | Benlysta | $59 | 4 payments
|
| Celltrion USA | Yuflyma | $48 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $42 | 2 payments
|
| Sobi | Kineret | $36 | 1 payment
|
| Lilly USA | Taltz | $33 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $30 | 1 payment
|
| Genzyme | Kevzara | $19 | 1 payment
|
2022: $892
| Janssen Biotech | Tremfya | $259 | 13 payments
|
| Ucb | Cimzia | $205 | 11 payments
|
| Abbvie | Rinvoq | $145 | 13 payments
|
| Amgen | Enbrel | $130 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $71 | 4 payments
|
| Pfizer | Xeljanz | $48 | 2 payments
|
| Radius Health | Tymlos | $22 | 1 payment
|
| GlaxoSmithKline | Benlysta | $13 | 1 payment
|
2021: $498
| Janssen Biotech | Tremfya | $152 | 20 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $106 | 5 payments
|
| Novartis Pharmaceuticals | Cosentyx | $58 | 3 payments
|
| AbbVie | Rinvoq | $50 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Saphnelo | $47 | 2 payments
|
| Amgen | Enbrel | $30 | 1 payment
|
| Ucb | Cimzia | $29 | 1 payment
|
| Genentech USA | Rituxan | $13 | 1 payment
|
| GlaxoSmithKline | Benlysta | $13 | 1 payment
|
2020: $110
| E.R. Squibb & Sons L.L.C. | Orencia | $67 | 4 payments
|
| GlaxoSmithKline | Benlysta | $27 | 2 payments
|
| Janssen Biotech | Simponi Aria | $16 | 1 payment
|
2019: $660
| Amgen | Prolia | $154 | 5 payments
|
| Janssen Scientific Affairs | Stelara | $124 | 1 payment
|
| Mallinckrodt Enterprises | Acthar | $111 | 1 payment
|
| GlaxoSmithKline | Benlysta | $50 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Orencia | $47 | 3 payments
|
| Novartis Pharmaceuticals | Cosentyx | $37 | 2 payments
|
| Genzyme | Kevzara | $25 | 1 payment
|
| Janssen Biotech | Simponi Aria | $23 | 2 payments
|
| Ucb | Cimzia | $21 | 1 payment
|
| Radius Health | Tymlos | $18 | 1 payment
|
| Medexus Pharma | Rasuvo | $13 | 1 payment
|
| Celgene | Otezla | $13 | 1 payment
|
| Genentech USA | Rituxan | $13 | 1 payment
|
| Horizon Therapeutics plc | Rayos | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1154455178
- Licence
- CA A129410, IN 01063328A, OH 35.093406California A129410: Current · expires 2027-10-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- OH 3118969
- Taxonomy
- Federal specialty code 207RR0500X (207RR0500X); Internal medicine (207R00000X)
- Mailing address
- 200 Jose Figueres Ave Ste 480, San Jose, CA, 95116
- NPI first listed
- 2007-03-14
- NPI last updated
- 2022-08-17
- NPI record certified
- 2022-08-17
This is when the NPI record was last certified, not a medical board exam.